{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:45:58Z","timestamp":1789854358146,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10157-022-02304-y","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T16:02:41Z","timestamp":1672156961000},"page":"211-217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mizoribine combined with steroids and dietary sodium restriction on the treatment of primary membranous nephropathy: a prospective study"],"prefix":"10.1007","volume":"27","author":[{"given":"Xichao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"issue":"3","key":"2304_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.kint.2016.09.048","volume":"91","author":"DC Cattran","year":"2017","unstructured":"Cattran DC, Brenchley PE. Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int. 2017;91(3):566\u201374. https:\/\/doi.org\/10.1016\/j.kint.2016.09.048.","journal-title":"Kidney Int"},{"issue":"9981","key":"2304_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/s0140-6736(15)60731-0","volume":"385","author":"P Ronco","year":"2015","unstructured":"Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient\u2019s care. Lancet (London, England). 2015;385(9981):1983\u201392. https:\/\/doi.org\/10.1016\/s0140-6736(15)60731-0.","journal-title":"Lancet (London, England)"},{"key":"2304_CR3","doi-asserted-by":"publisher","unstructured":"Chapter 7: 2012 Idiopathic membranous nephropathy. Kidney international supplements. 2(2):186\u201397. doi:https:\/\/doi.org\/10.1038\/kisup.2012.20","DOI":"10.1038\/kisup.2012.20"},{"key":"2304_CR4","doi-asserted-by":"publisher","first-page":"e930097","DOI":"10.12659\/msm.930097","volume":"27","author":"L Wu","year":"2021","unstructured":"Wu L, Lai J, Ling Y, Weng Y, Zhou S, Wu S, et al. A review of the current practice of diagnosis and treatment of idiopathic membranous nephropathy in China. Med Sci Monit. 2021;27:e930097. https:\/\/doi.org\/10.12659\/msm.930097.","journal-title":"Med Sci Monit"},{"issue":"9","key":"2304_CR5","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.ekir.2020.06.030","volume":"5","author":"S Sethi","year":"2020","unstructured":"Sethi S, Kumar S, Lim K, Jordan SC. Obinutuzumab is effective for the treatment of refractory membranous nephropathy. Kidney Int Rep. 2020;5(9):1515\u20138. https:\/\/doi.org\/10.1016\/j.ekir.2020.06.030.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"2304_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.ajkd.2020.02.444","volume":"76","author":"N Klomjit","year":"2020","unstructured":"Klomjit N, Fervenza FC, Zand L. Successful treatment of patients with refractory PLA(2)R-associated membranous nephropathy with obinutuzumab: a report of 3 cases. Am J Kidney Dis. 2020;76(6):883\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2020.02.444.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2304_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ndt\/gfz086","volume":"35","author":"C Barrett","year":"2020","unstructured":"Barrett C, Willcocks LC, Jones RB, Tarzi RM, Henderson RB, Cai G, et al. Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy. Nephrol Dial Transplant. 2020;35(4):599\u2013606. https:\/\/doi.org\/10.1093\/ndt\/gfz086.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2304_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s10157-018-1628-5","volume":"23","author":"A Mizutani","year":"2019","unstructured":"Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. Clin Exp Nephrol. 2019;23(2):244\u201350. https:\/\/doi.org\/10.1007\/s10157-018-1628-5.","journal-title":"Clin Exp Nephrol"},{"key":"2304_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lfs.2016.04.012","volume":"154","author":"X Wang","year":"2016","unstructured":"Wang X, Song X, Liu Y, Zhang W, An W, Tu Y. Treatment of membranous nephropathy with mizoribine: a control trial. Life Sci. 2016;154:75\u20138. https:\/\/doi.org\/10.1016\/j.lfs.2016.04.012.","journal-title":"Life Sci"},{"issue":"4","key":"2304_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s11255-020-02680-y","volume":"53","author":"X Wang","year":"2021","unstructured":"Wang X, Zhang M, Zhang W, Liu Y, Han Y, Chang W. Effect of mizoribine pulse therapy in adult membranous nephropathy. Int Urol Nephrol. 2021;53(4):725\u201331. https:\/\/doi.org\/10.1007\/s11255-020-02680-y.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2304_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","volume":"43","author":"A Pasini","year":"2017","unstructured":"Pasini A, Benetti E, Conti G, Ghio L, Lepore M, Massella L, et al. The Italian society for pediatric nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I-diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr. 2017;43(1):41. https:\/\/doi.org\/10.1186\/s13052-017-0356-x.","journal-title":"Ital J Pediatr"},{"issue":"2","key":"2304_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ncp.10622","volume":"36","author":"KJ Hampson","year":"2021","unstructured":"Hampson KJ, Gay ML, Band ME. Pediatric nephrotic syndrome: pharmacologic and nutrition management. Nutr Clin Pract. 2021;36(2):331\u201343. https:\/\/doi.org\/10.1002\/ncp.10622.","journal-title":"Nutr Clin Pract"},{"issue":"6","key":"2304_CR13","doi-asserted-by":"publisher","first-page":"CD010070","DOI":"10.1002\/14651858.CD010070.pub3","volume":"6","author":"EJ McMahon","year":"2021","unstructured":"McMahon EJ, Campbell KL, Bauer JD, Mudge DW, Kelly JT. Altered dietary salt intake for people with chronic kidney disease. The Cochrane Database Sys Rev. 2021;6(6):CD010070. https:\/\/doi.org\/10.1002\/14651858.CD010070.pub3.","journal-title":"The Cochrane Database Sys Rev"},{"key":"2304_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/nu10060732","author":"C Garofalo","year":"2018","unstructured":"Garofalo C, Borrelli S, Provenzano M, De Stefano T, Vita C, Chiodini P, et al. Dietary salt restriction in chronic kidney disease: a meta-analysis of randomized clinical trials. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10060732.","journal-title":"Nutrients"},{"issue":"7654","key":"2304_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/bmj.39576.709711.80","volume":"336","author":"RP Hull","year":"2008","unstructured":"Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ (Clinical research ed). 2008;336(7654):1185\u20139. https:\/\/doi.org\/10.1136\/bmj.39576.709711.80.","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"2304_CR16","doi-asserted-by":"publisher","first-page":"003965","DOI":"10.1002\/14651858.CD003965.pub3","volume":"3","author":"P Natale","year":"2020","unstructured":"Natale P, Palmer SC, Ruospo M, Saglimbene VM, Craig JC, Vecchio M, et al. Immunosuppressive agents for treating IgA nephropathy. The Cochrane Database Sys Rev. 2020;3(3):003965. https:\/\/doi.org\/10.1002\/14651858.CD003965.pub3.","journal-title":"The Cochrane Database Sys Rev"},{"issue":"6","key":"2304_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s10157-018-1597-8","volume":"22","author":"H Kagawa","year":"2018","unstructured":"Kagawa H, Hiromasa T, Yamanaka R, Hayashi R, Tsunashima Y, Inoue T, et al. The first year results of mizoribine\/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis. Clin Exp Nephrol. 2018;22(6):1371\u20138. https:\/\/doi.org\/10.1007\/s10157-018-1597-8.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"2304_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/iju.13476","volume":"25","author":"T Nishioka","year":"2018","unstructured":"Nishioka T, Yoshimura N, Ushigome H, Watarai Y, Nishimura K, Akioka K, et al. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: a Japanese multicenter study. Int J Urol. 2018;25(2):141\u20135. https:\/\/doi.org\/10.1111\/iju.13476.","journal-title":"Int J Urol"},{"issue":"5","key":"2304_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/nep.12052","volume":"18","author":"DW Johnson","year":"2013","unstructured":"Johnson DW, Atai E, Chan M, Phoon RK, Scott C, Toussaint ND, et al. KHA-CARI guideline: early chronic kidney disease: detection, prevention and management. Nephrology (Carlton). 2013;18(5):340\u201350. https:\/\/doi.org\/10.1111\/nep.12052.","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"2304_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/00007890-198302000-00007","volume":"35","author":"K Kamata","year":"1983","unstructured":"Kamata K, Okubo M, Ishigamori E, Masaki Y, Uchida H, Watanabe K, et al. Immunosuppressive effect of bredinin on cell-mediated and humoral immune reactions in experimental animals. Transplantation. 1983;35(2):144\u20139. https:\/\/doi.org\/10.1097\/00007890-198302000-00007.","journal-title":"Transplantation"},{"issue":"6","key":"2304_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10157-016-1340-2","volume":"21","author":"T Saito","year":"2017","unstructured":"Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, et al. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome. Clin Exp Nephrol. 2017;21(6):961\u201370. https:\/\/doi.org\/10.1007\/s10157-016-1340-2.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2304_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12882-018-1033-z","volume":"19","author":"T Hama","year":"2018","unstructured":"Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, et al. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial). BMC Nephrol. 2018;19(1):223. https:\/\/doi.org\/10.1186\/s12882-018-1033-z.","journal-title":"BMC Nephrol"},{"issue":"9","key":"2304_CR23","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1681\/asn.2006070732","volume":"18","author":"A Nakajo","year":"2007","unstructured":"Nakajo A, Khoshnoodi J, Takenaka H, Hagiwara E, Watanabe T, Kawakami H, et al. Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance. J Am Soc Nephrol. 2007;18(9):2554\u201364. https:\/\/doi.org\/10.1681\/asn.2006070732.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2304_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/bbrc.2000.3104","volume":"274","author":"S Takahashi","year":"2000","unstructured":"Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H. Functional interaction of the immunosuppressant mizoribine with the 14\u20133-3 protein. Biochem Biophys Res Commun. 2000;274(1):87\u201392. https:\/\/doi.org\/10.1006\/bbrc.2000.3104.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2304_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","volume":"58","author":"K Yoshioka","year":"2000","unstructured":"Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, et al. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int. 2000;58(1):317\u201324. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00168.x.","journal-title":"Kidney Int"},{"issue":"7","key":"2304_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa1311989","volume":"371","author":"A Mente","year":"2014","unstructured":"Mente A, O\u2019Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371(7):601\u201311. https:\/\/doi.org\/10.1056\/NEJMoa1311989.","journal-title":"N Engl J Med"},{"key":"2304_CR27","doi-asserted-by":"publisher","first-page":"f1325","DOI":"10.1136\/bmj.f1325","volume":"346","author":"FJ He","year":"2013","unstructured":"He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: cochrane systematic review and meta-analysis of randomised trials. BMJ (Clinical research ed). 2013;346:f1325. https:\/\/doi.org\/10.1136\/bmj.f1325.","journal-title":"BMJ (Clinical research ed)"},{"key":"2304_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nu11091970","author":"A Grillo","year":"2019","unstructured":"Grillo A, Salvi L, Coruzzi P, Salvi P, Parati G. Sodium intake and hypertension. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11091970.","journal-title":"Nutrients"},{"issue":"5","key":"2304_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1681\/asn.2007060693","volume":"19","author":"L Vogt","year":"2008","unstructured":"Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999\u20131007. https:\/\/doi.org\/10.1681\/asn.2007060693.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2304_CR30","doi-asserted-by":"publisher","first-page":"e93513","DOI":"10.1371\/journal.pone.0093513","volume":"9","author":"T Doi","year":"2014","unstructured":"Doi T, Doi S, Nakashima A, Ueno T, Yokoyama Y, Kohno N, et al. Mizoribine ameliorates renal injury and hypertension along with the attenuation of renal caspase-1 expression in aldosterone-salt-treated rats. PLoS ONE. 2014;9(4):e93513. https:\/\/doi.org\/10.1371\/journal.pone.0093513.","journal-title":"PLoS ONE"},{"issue":"2","key":"2304_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.autrev.2018.12.001","volume":"18","author":"K Sharif","year":"2019","unstructured":"Sharif K, Amital H, Shoenfeld Y. Corrigendum to 'The role of dietary sodium in autoimmune diseases: The salty truth\u2019 [AUTREV 17\u201311 (2018) 1069\u20131073]. Autoimmun Rev. 2019;18(2):214. https:\/\/doi.org\/10.1016\/j.autrev.2018.12.001.","journal-title":"Autoimmun Rev"},{"key":"2304_CR32","doi-asserted-by":"publisher","first-page":"155452","DOI":"10.1016\/j.cyto.2021.155452","volume":"141","author":"R Motavalli","year":"2021","unstructured":"Motavalli R, Etemadi J, Soltani-Zangbar MS, Ardalan MR, Kahroba H, Roshangar L, et al. Altered Th17\/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy. Cytokine. 2021;141:155452. https:\/\/doi.org\/10.1016\/j.cyto.2021.155452.","journal-title":"Cytokine"},{"key":"2304_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041255","author":"M Cirillo","year":"2021","unstructured":"Cirillo M, Cavallo P, Zulli E, Villa R, Veneziano R, Costanzo S, et al. Sodium intake and proteinuria\/albuminuria in the population-observational cross-sectional study. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13041255.","journal-title":"Nutrients"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02304-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-022-02304-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02304-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T17:23:15Z","timestamp":1677172995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-022-02304-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2304"],"URL":"https:\/\/doi.org\/10.1007\/s10157-022-02304-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]},"assertion":[{"value":"30 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}